Alta LS has a consistent and versatile investment strategy that takes advantage of its team experience and skills to source and manage the right opportunities across all life sciences’ sectors, connecting the Spanish and European ecosystem with the venture capital expertise and know how of Silicon Valley.
The pillars of our strategy are:
- A multistage fund: we invest in companies at all the stages of development, from seed through commercialization.
- A bridge fund: utilizing Guy Nohra's leading position as a respected and seasoned investor in the US market, Alta LS acts as a bridge fund between Silicon Valley and Spain, becoming a platform for IPOs and M&A Transactions.
- Focused primarily on investments in Spain, but open to investments outside Spain.
- A lead investor with a hands on approach, working alongside management teams to reach significant value creating milestones.
- With a defined exit strategy, driven by public offerings in the US and global M&A, creating a Spanish pipeline for the US public markets.
- We focus our investments in biotechnology and biopharma products, medical devices, diagnostics, genomics and digital health.
